Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 2
2014 4
2015 2
2016 7
2017 5
2018 8
2019 4
2020 4
2021 2
2022 2
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin.
de Jong FC, Laajala TD, Hoedemaeker RF, Jordan KR, van der Made ACJ, Boevé ER, van der Schoot DKE, Nieuwkamer B, Janssen EAM, Mahmoudi T, Boormans JL, Theodorescu D, Costello JC, Zuiverloon TCM. de Jong FC, et al. Among authors: laajala td. Sci Transl Med. 2023 May 24;15(697):eabn4118. doi: 10.1126/scitranslmed.abn4118. Epub 2023 May 24. Sci Transl Med. 2023. PMID: 37224225 Free PMC article.
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells.
Kauko O, O'Connor CM, Kulesskiy E, Sangodkar J, Aakula A, Izadmehr S, Yetukuri L, Yadav B, Padzik A, Laajala TD, Haapaniemi P, Momeny M, Varila T, Ohlmeyer M, Aittokallio T, Wennerberg K, Narla G, Westermarck J. Kauko O, et al. Among authors: laajala td. Sci Transl Med. 2018 Jul 18;10(450):eaaq1093. doi: 10.1126/scitranslmed.aaq1093. Sci Transl Med. 2018. PMID: 30021885 Free PMC article.
Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes.
Jillson LK, Yette GA, Laajala TD, Tilley WD, Costello JC, Cramer SD. Jillson LK, et al. Among authors: laajala td. Cancers (Basel). 2021 Jun 30;13(13):3272. doi: 10.3390/cancers13133272. Cancers (Basel). 2021. PMID: 34208794 Free PMC article. Review.
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer.
Mason M, Lapuente-Santana Ó, Halkola AS, Wang W, Mall R, Xiao X, Kaufman J, Fu J, Pfeil J, Banerjee J, Chung V, Chang H, Chasalow SD, Lin HY, Chai R, Yu T, Finotello F, Mirtti T, Mäyränpää MI, Bao J, Verschuren EW, Ahmed EI, Ceccarelli M, Miller LD, Monaco G, Hendrickx WRL, Sherif S, Yang L, Tang M, Gu SS, Zhang W, Zhang Y, Zeng Z, Das Sahu A, Liu Y, Yang W, Bedognetti D, Tang J, Eduati F, Laajala TD, Geese WJ, Guinney J, Szustakowski JD, Vincent BG, Carbone DP. Mason M, et al. Among authors: laajala td. J Transl Med. 2024 Feb 21;22(1):190. doi: 10.1186/s12967-023-04705-3. J Transl Med. 2024. PMID: 38383458 Free PMC article.
Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246-Sensitive Disease Subtype.
Cvrljevic AN, Butt U, Huhtinen K, Grönroos TJ, Böckelman C, Lassus H, Butzow R, Haglund C, Kaipio K, Arsiola T, Laajala TD, Connolly DC, Ristimäki A, Carpen O, Pouwels J, Westermarck J. Cvrljevic AN, et al. Among authors: laajala td. Mol Cancer Ther. 2022 Jul 5;21(7):1236-1245. doi: 10.1158/1535-7163.MCT-21-0622. Mol Cancer Ther. 2022. PMID: 35364610 Free PMC article.
NPEPPS Is a Druggable Driver of Platinum Resistance.
Jones RT, Scholtes M, Goodspeed A, Akbarzadeh M, Mohapatra S, Feldman LE, Vekony H, Jean A, Tilton CB, Orman MV, Romal S, Deiter C, Kan TW, Xander N, Araki SP, Joshi M, Javaid M, Clambey ET, Layer R, Laajala TD, Parker SJ, Mahmoudi T, Zuiverloon TCM, Theodorescu D, Costello JC. Jones RT, et al. Among authors: laajala td. Cancer Res. 2024 Mar 27:OF1-OF20. doi: 10.1158/0008-5472.CAN-23-1976. Online ahead of print. Cancer Res. 2024. PMID: 38535994
MRI-Targeted Prostate Biopsy Introduces Grade Inflation and Overtreatment.
Batouche AO, Czeizler E, Lehto TP, Erickson A, Shadbahr T, Laajala TD, Pohjonen J, Vickers AJ, Mirtti T, Rannikko AS. Batouche AO, et al. Among authors: laajala td. medRxiv [Preprint]. 2024 Jan 10:2024.01.10.24300922. doi: 10.1101/2024.01.10.24300922. medRxiv. 2024. PMID: 38260466 Free PMC article. Preprint.
Community mining of open clinical trial data.
Laajala TD, Guinney J, Costello JC. Laajala TD, et al. Oncotarget. 2017 Sep 13;8(47):81721-81722. doi: 10.18632/oncotarget.20853. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137211 Free PMC article. No abstract available.
Microbiome-based risk prediction in incident heart failure: a community challenge.
Erawijantari PP, Kartal E, Liñares-Blanco J, Laajala TD, Feldman LE; FINRISK Microbiome DREAM Challenge and ML4Microbiome Communities; Carmona-Saez P, Shigdel R, Claesson MJ, Bertelsen RJ, Gomez-Cabrero D, Minot S, Albrecht J, Chung V, Inouye M, Jousilahti P, Schultz JH, Friederich HC, Knight R, Salomaa V, Niiranen T, Havulinna AS, Saez-Rodriguez J, Levinson RT, Lahti L. Erawijantari PP, et al. Among authors: laajala td. medRxiv [Preprint]. 2023 Oct 12:2023.10.12.23296829. doi: 10.1101/2023.10.12.23296829. medRxiv. 2023. PMID: 37873403 Free PMC article. Preprint.
49 results